©Author(s) (or their employer(s)) 2026.
World J Psychiatry. Mar 19, 2026; 16(3): 114036
Published online Mar 19, 2026. doi: 10.5498/wjp.v16.i3.114036
Published online Mar 19, 2026. doi: 10.5498/wjp.v16.i3.114036
Table 1 Characteristics of the study participants (n = 619), n (%)
| Characteristic | Value |
| Age, years, mean ± SD | 36.03 ± 10.69 |
| Male | 323 (52.18) |
| Female | 296 (47.82) |
| Illness duration, years, mean ± SD | 9.24 ± 8.15 |
| Baseline PANSS total score, mean ± SD | 94.85 ± 14.02 |
| Atypical antipsychotics | 587 (94.83) |
| Typical antipsychotics | 32 (5.17) |
- Citation: Hou L, Chen R, Huang CB, Shi WJ, Wu LL. Clinical symptom improvement following modified electroconvulsive therapy is associated with modulation of peripheral inflammatory markers in schizophrenia. World J Psychiatry 2026; 16(3): 114036
- URL: https://www.wjgnet.com/2220-3206/full/v16/i3/114036.htm
- DOI: https://dx.doi.org/10.5498/wjp.v16.i3.114036